Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment
NCT01087333
Adult T Cell Lymphoma (ATL), Anemia
Bethesda, Maryland, United States
View Trial DetailsNCT Number: NCT06774677
This is a national multi-centre, experimental, cross-sectional, non-profit study.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello, Palermo, PA, Italy
Extracellular vesicles are small particles circulating in plasma and documented as key players of intercellular crosstalk thanks to their cargo of proteins, lipids, and nucleic acids. The driving hypothesis of this study is that in Hairy Cell Leukemia-derived extracellular vesicles contribute to the maintenance of the tumor clone through regulation of selected key cells of the tumor microenvironment including immune cells and stromal cells, likely favoring immune evasion and marrow fibrosis. As a consequence, these circulating particles may be instrumental at identifying a biology-related, disease-specific and extracellular vesicle-based signature associated to outcomes.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
for patients:
Inclusion criteria
for Healthy Donors:
Exclusion criteria
Time frame: 1 years
Verify whether hairy cell leukemia patients at different status (at diagnosis, in complete remission > 2 years, or relapsed meeting treatment indications) display specific extracellular vesicle-based signatures.
Time frame: 1 years
Elucidate whether plasma-derived extracellular vesicles of hairy cell leukemia patients and healthy donors and in vitro hairy cell-derived extracellular vesicles may functionally educate the immune microenvironment. Elucidate whether plasma-derived extracellular vesicles of patients and healthy donors may functionally affect the isolated hairy cells. Understand whether plasma-derived extracellular vesicles of patients and healthy donors and in vitro hairy cell-derived extracellular vesicles might shape the stromal microenvironment toward fibrosis.
Contact information is provided by the study sponsor or research team.
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01087333
Adult T Cell Lymphoma (ATL), Anemia
Bethesda, Maryland, United States
View Trial DetailsNCT06764524
Hairy Cell Leukemia (HCL), Hematologic Diseases
Bologna, Italy
View Trial DetailsNCT06782854
Chronic Disease, Chronic Lymphocytic Leukemia
Bologna, Italy
View Trial DetailsNCT02157181
Hairy Cell Leukemia (HCL), Hematologic Diseases
Ansbach, Germany
View Trial Details